Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Protocol for phase IIb study of metadoxine extended release sent to FDA

April 14, 2014

Study will evaluate TSO in pediatric patients with autism spectrum disorder

April 14, 2014

Lytix Biopharma forms Pharmasum Therapeutics to focus on dementia

April 14, 2014

Impax resubmits NDA for IPX-066

April 14, 2014

Pfizer discloses novel Abeta production inhibitors

April 14, 2014

Pfizer returns Aversion product rights to Acura Pharmaceuticals

April 11, 2014

Neurolixis receives grant to test NLX-101 in animal models of Rett syndrome

April 11, 2014

Tetra Discovery collaborates with Broad Institute's Stanley Center on schizophrenia

April 11, 2014

Scientists at Roche design novel agents for CNS disorders

April 11, 2014

PRX-002 enters phase I for Parkinson's disease

April 11, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...